4.6 Article

Life-Threatening Cardiogenic Shock Related to Venlafaxine Poisoning-A Case Report with Metabolomic Approach

期刊

METABOLITES
卷 13, 期 3, 页码 -

出版社

MDPI
DOI: 10.3390/metabo13030353

关键词

metabolomics; molecular network; analytical toxicology; clinical toxicology; venlafaxine; poisoning; ECMO; management; cardiotoxicity

向作者/读者索取更多资源

Metabolomics in clinical toxicology aims to identify and semi-quantify a wide range of endogenous and exogenous metabolites. In this study, a three-step workflow was developed to investigate the metabolic impact of the antidepressant drug venlafaxine in a poisoned patient. Targeted quantitative and untargeted semi-quantitative metabolomic analyses were performed to determine the plasma kinetics of venlafaxine and its metabolites, and correlations between the metabolomic data and endogenous metabolites were explored. This preliminary study is a first step towards the application of toxicometabolomics in clinical toxicology and provides a useful workflow for identifying toxicity biomarkers.
Metabolomics in clinical toxicology aim at reliably identifying and semi-quantifying a broad array of endogenous and exogenous metabolites using dedicated analytical methods. Here, we developed a three-step-based workflow to investigate the metabolic impact of the antidepressant drug venlafaxine in a poisoned patient who developed life-threatening cardiac failure managed with extracorporeal membrane oxygenation. Both targeted quantitative and untargeted semi-quantitative metabolomic analyses using liquid chromatography hyphenated to high-resolution tandem mass spectrometry were performed to determine the plasma kinetics of venlafaxine, O-desmethyl-venlafaxine, and N-desmethyl-venlafaxine and to identify sixteen different venlafaxine-derived metabolites including one unknown (i.e., venlafaxine conjugated to a hexosyl-radical), respectively. Correlations between the quantitative metabolomic data and annotated endogenous metabolites suggested impaired amino acid and lipid metabolism, Krebs cycle, and kynurenine pathway. This preliminary study represents a first step towards a more extensive application of toxicometabolomics in clinical toxicology and a useful workflow to identify the biomarkers of toxicity.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据